Kennedy Capital Management’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
Kennedy Capital Management's VCYT Position: Q3 2026 in Review
Kennedy Capital Management sold out of Veracyte (VCYT) in Q3 2026, closing a stake of 52,978 shares — an estimated $3.11M sold.
Kennedy Capital Management first reported a position in VCYT in Q1 2026 and held it in 2 quarters. The position peaked at $3.11M in Q2 2026. 383 funds tracked by Wall St. Rank hold VCYT as of Q3 2026.
- Kennedy Capital Management reported no remaining Veracyte position as of Q3 2026 after selling out during the quarter.
- Kennedy Capital Management sold 52,978 Veracyte shares in Q3 2026, an estimated $3.11M.
- Kennedy Capital Management first reported a position in Veracyte in Q1 2026 and held it in 2 quarters.
- Kennedy Capital Management's Veracyte position peaked at $3.11M in Q2 2026.
- 383 funds tracked by Wall St. Rank held Veracyte as of Q3 2026.
Based on Kennedy Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.